Recombinant Bacillus subtilis Uncharacterized ABC transporter permease yclI (yclI)

What is YclI and how is it classified among ABC transporters?

YclI is an uncharacterized ABC transporter permease in Bacillus subtilis, identified with the gene ID 938279 and UniProt ID P94412 . ABC transporters typically consist of four core domains: two nucleotide binding domains (NBDs) that hydrolyze ATP and two transmembrane domains (TMDs) that enable substrate transport across cell membranes . Based on structural characteristics, YclI functions as a transmembrane component (permease) of an ABC transporter system. ABC transporters in B. subtilis are classified into three main groups: importers (which require a substrate binding protein), exporters, and those with regulatory functions beyond substrate transport . Though YclI's precise classification remains unconfirmed, its permease designation suggests it forms part of the transmembrane domain critical for substrate translocation.

What expression patterns does YclI exhibit under different growth conditions?

While the specific expression patterns of YclI have not been directly addressed in the provided search results, insights can be drawn from studies of other ABC transporters in B. subtilis. Many ABC transporters show differential expression patterns depending on environmental conditions and growth phases. For instance, the YtrBCDEF ABC transporter system is induced in the presence of cell wall-targeting antibiotics such as ramoplanin, bacitracin, and vancomycin . YtrE specifically serves as a marker protein for inhibition of membrane-bound peptidoglycan biosynthesis steps . YtrBCDEF expression is also induced following cold shock exposure .

Research methodology to characterize YclI expression patterns would typically include:

• Transcriptional reporter fusions (e.g., yclI-lacZ)

• qRT-PCR analysis under various growth conditions

• Ribosome profiling for translational regulation assessment

• Proteomics approaches to quantify protein abundance

What is the genomic context of yclI in Bacillus subtilis?

The yclI gene (Gene ID: 938279) is annotated as an "ABC transporter permease" in Bacillus subtilis subsp. subtilis str. 168 . While the search results don't provide complete information about the genomic neighborhood, understanding genomic context is crucial for functional insights. ABC transporter genes in B. subtilis are typically organized in operons that include genes encoding the nucleotide-binding domain proteins, transmembrane domain proteins, and sometimes substrate-binding proteins or regulatory elements.

A thorough genomic context analysis would involve:

• Identification of adjacent genes and their functional annotations

• Analysis of potential operon structure through transcriptomic data

• Examination of regulatory elements in the promoter region

• Comparative genomics across related Bacillus species to identify conservation patterns

What methodologies are most effective for functional characterization of YclI?

Functional characterization of uncharacterized ABC transporters like YclI requires a multi-faceted approach. Based on established methodologies for ABC transporter research, the following experimental strategies are recommended:

Genetic Approaches:

• Construction of clean deletion mutants (ΔyclI) using allelic replacement

• Complementation studies with wild-type and mutated variants

• Conditional expression systems to control YclI levels

• Suppressor mutation screening to identify functional networks

Biochemical Characterization:

• Membrane vesicle transport assays to measure substrate translocation

• ATPase activity assays to quantify energy utilization

• Protein purification and reconstitution in liposomes

• Substrate binding assays using purified components

Structural Biology:

• Cryo-electron microscopy for structural determination

• X-ray crystallography of individual domains or full transporter

• Molecular dynamics simulations to predict conformational changes

• Cross-linking and mass spectrometry for identifying domain interactions

Physiological Assessment:

• Phenotypic profiling under various stress conditions

• Metabolomic analysis to identify accumulated substrates in mutants

• Cell envelope integrity assays (e.g., sensitivity to detergents, osmotic stress)

• Growth rate and competitive fitness assays

This comprehensive approach has proven successful for characterizing other ABC transporters in B. subtilis, such as BmrA and BmrCD, which were shown to transport various substrates including Hoechst 33342, ethidium bromide, and doxorubicin through inside-out membrane vesicle assays .

How might YclI contribute to antibiotic resistance in Bacillus subtilis?

While the specific role of YclI in antibiotic resistance is not directly addressed in the search results, several mechanisms by which ABC transporters confer resistance in B. subtilis have been documented, providing a framework for investigating YclI's potential contributions:

Potential Resistance Mechanisms:

To investigate YclI's role in antibiotic resistance, researchers should:

• Perform minimum inhibitory concentration (MIC) assays with various antibiotics comparing wild-type and ΔyclI strains

• Analyze transcriptomic responses to antibiotic exposure in presence/absence of YclI

• Investigate potential interactions with known resistance determinants through genetic and biochemical approaches

• Monitor the accumulation and efflux of fluorescently labeled antibiotics in cellular systems with modulated YclI expression

What role might YclI play in cell wall biosynthesis and homeostasis?

Several ABC transporters in B. subtilis influence cell wall processes, suggesting potential roles for YclI in this essential aspect of bacterial physiology. For example, overexpression of the YtrBCDEF ABC transporter leads to the production of a thicker peptidoglycan layer in B. subtilis . Additionally, the expression of the ytrGABCDEF operon is induced in the presence of cell wall-acting antibiotics such as ramoplanin, bacitracin, and vancomycin .

To investigate YclI's potential role in cell wall processes, researchers should consider:

Experimental Approaches:

• Cell Wall Composition Analysis:

  • Peptidoglycan structural analysis in ΔyclI mutants

  • Quantification of wall teichoic acid content and composition

  • Measurement of lipid II cycle intermediates

• Morphological Studies:

  • Electron microscopy to assess cell envelope ultrastructure

  • Fluorescence microscopy with cell wall-specific dyes

  • Cell shape and division pattern analysis

• Interaction Studies:

  • Bacterial two-hybrid assays to identify interactions with cell wall synthesis enzymes

  • Co-immunoprecipitation of YclI with potential protein partners

  • Localization studies using fluorescent protein fusions

• Physiological Tests:

  • Susceptibility to cell wall hydrolytic enzymes (e.g., lysozyme)

  • Osmotic stress resistance profiling

  • Cell lysis rates under various growth conditions

How can substrate specificity of YclI be experimentally determined?

Identifying the substrate(s) of uncharacterized transporters like YclI presents a significant challenge. Based on methodologies applied to other ABC transporters, the following approaches would be effective:

Direct Transport Assays:

• Inside-out membrane vesicles containing overexpressed YclI

• Purified YclI reconstituted in proteoliposomes

• Whole-cell uptake/export assays with radiolabeled or fluorescent substrates

Indirect Approaches:

• Metabolomic profiling comparing wild-type and ΔyclI strains

• Growth phenotyping on various nutrient sources

• Suppressor mutation analysis identifying compensatory pathways

Computational Methods:

• Structural homology modeling to predict substrate binding pockets

• Molecular docking simulations with potential substrates

• Sequence-based substrate prediction using machine learning

Genetic Approaches:

• Transcriptomic analysis under various growth conditions

• Identification of co-regulated genes suggesting functional relationships

• Heterologous expression in surrogate hosts with defined backgrounds

For example, the substrate specificity of the YtrBCDEF transporter was investigated through expression studies and growth phenotypes, leading to its proposed role in acetoin import . Similar methodologies could reveal YclI's substrate preference.

How does ATP hydrolysis couple to transport function in YclI-containing ABC transporter systems?

While specific information about YclI's ATP hydrolysis mechanism is not provided in the search results, understanding the general principles of ABC transporter energetics is crucial for characterizing this system. ABC transporters typically couple ATP binding and hydrolysis to conformational changes that drive substrate translocation.

To investigate this coupling in YclI-containing systems, researchers should consider:

Key Methodological Approaches:

For example, studies with the B. subtilis multidrug transporter BmrCD demonstrated ATP-dependent transport of substrates like Hoechst 33342 and ethidium bromide into reconstituted vesicles, and this transport activity could be inhibited by orthovanadate, an ATPase inhibitor . Similar approaches would be valuable for characterizing YclI's energy coupling mechanism.

How might understanding YclI function contribute to antimicrobial development?

ABC transporters represent potential targets for antimicrobial development due to their essential roles in bacterial physiology and virulence. Understanding YclI's function could contribute to this field in several ways:

• If YclI functions in antibiotic resistance: Inhibitors could serve as adjuvants to enhance antibiotic efficacy

• If YclI transports essential nutrients: Blocking its function could starve bacteria of critical resources

• If YclI participates in cell wall processes: Targeting it could disrupt cell envelope integrity

Research methodologies to explore YclI as an antimicrobial target would include:

• High-throughput screening for inhibitors of YclI function

• Structure-based drug design targeting critical domains

• Combination therapy approaches with existing antibiotics

• Assessment of resistance development against YclI-targeting compounds

What comparative insights can be gained by studying YclI homologs across bacterial species?

Comparative analysis of YclI homologs across diverse bacteria can provide valuable insights into its evolutionary conservation, functional importance, and specialization. Methodological approaches include:

• Phylogenetic Analysis:

  • Construction of phylogenetic trees to map evolutionary relationships

  • Identification of conserved and variable regions suggesting functional domains

  • Assessment of selection pressures on different protein regions

• Functional Complementation:

  • Cross-species complementation experiments to test functional conservation

  • Heterologous expression studies to assess substrate specificity differences

  • Domain-swapping experiments to identify species-specific functional elements

• Genomic Context Analysis:

  • Examination of operon structure conservation across species

  • Identification of co-evolved gene clusters suggesting functional relationships

  • Analysis of regulatory elements governing expression

For instance, phylogenetic analysis revealed that BceAB-like transporters are nearly exclusively found in bacteria of the phylum Firmicutes and confer resistance to specific antimicrobials . Similar analysis of YclI could reveal its distribution and potential specialization across bacterial taxa.

How does YclI expression change during different growth phases and stress conditions?

Understanding the regulation of YclI expression provides insights into its physiological roles. While specific data for YclI is not provided in the search results, studies of other ABC transporters in B. subtilis demonstrate condition-dependent expression patterns.

Methodological Approaches:

• Transcriptional Profiling:

  • RNA-seq across growth phases and stress conditions

  • Promoter-reporter fusion assays to monitor expression dynamics

  • Identification of transcription factor binding sites

• Proteomics:

  • Quantitative proteomics to measure protein abundance changes

  • Pulse-chase experiments to determine protein turnover rates

  • Post-translational modification analysis

• Regulation Mechanism Studies:

  • Identification of transcriptional regulators through genetic screens

  • Chromatin immunoprecipitation to confirm direct regulatory interactions

  • Analysis of regulatory small RNAs affecting expression

For example, the genes encoding the BmrCD transporter are induced in the presence of various antibiotics, particularly those targeting ribosomes . The YtrBCDEF system is induced by cell wall-acting antibiotics and cold shock . Similar studies of YclI expression would reveal its regulatory patterns and potential functional roles.